Western blotting results confirmed that vortioxetine hydrobromide reduced the levels of p-STAT3 Y705, c-Myc, Bcl-2 and Mcl-1 in PDX tumor xenografts (Fig. 7H). Here, MCL1 is linked to neoplasm.